Randomized Controlled Trial
Copyright ©The Author(s) 2016.
World J Gastrointest Endosc. Nov 16, 2016; 8(19): 716-722
Published online Nov 16, 2016. doi: 10.4253/wjge.v8.i19.716
Figure 3
Figure 3 A representative case in the lansoprazole group. The area inside the yellow line was calculated using ImageJ. We placed measuring forceps on the ulcer base to use as a scale. The ulcer base gradually shrank and there were no adverse events. The shrinking rates on days 8 and 28 were 27.1% and 96.3%, respectively.